Treatment of non-small cell lung cancer with Yiqi Buxue prescriptions combined with adjuvant chemotherapy on the cancer therapy-related cardiovascular toxicity: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of non-small cell lung cancer with Yiqi Buxue prescriptions combined with adjuvant chemotherapy on the cancer therapy-related cardiovascular toxicity: A systematic review and meta-analysis

Published:2024-04 Issue: Volume:323 Page:117665
ISSN:0378-8741
Container-title:Journal of Ethnopharmacology
language:en
Short-container-title:Journal of Ethnopharmacology

Author:

Huang Hangxing,Liu Beicheng,Chen Mengzhen,Qin Yanfang,Li Jianyu,Li Simin,Xu Xue

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology

Reference42 articles.

1. Cardiac immune-related adverse events in immune checkpoint inhibition therapy;Brumbaugh;Cardiol. Rev.,2019

2. Integrated DIA proteomics and lipidomics analysis on non-small cell lung cancer patients with TCM syndromes;Cang;Chin. Med.,2021

3. The effect of Shenyi capsule on non-small-cell lung cancer combined with chemotherapy from the yin-yang perspective;Cai;Evid. Based. Complement. Alternat. Med.,2021

4. Jianpi bushen, a traditional Chinese medicine therapy, combined with chemotherapy for gastric cancer treatment: a meta-analysis of randomized controlled trials;Chen;Evid. Based. Complement. Alternat. Med.,2018

5. Strengthening Systematic Reviews in Public Health: Guidance in the Cochrane Handbook for Systematic Reviews of Interventions;Cumpston,2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP